Combined-modality therapy for rectal cancer: Future prospects

被引：4

作者：

Czito, Brian G.

Willett, Christopher G.

Bendell, Johanna C.

机构：

[1] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA

[2] Duke Univ, Med Ctr, Div Transplantat & Oncol, Durham, NC 27710 USA

来源：

CLINICAL COLORECTAL CANCER | 2007年 / 6卷 / 09期

关键词：

bevacizumab; capecitabine; chemotherapy; epidermal growth factor receptor; irinotecan; oxaliplatin;

D O I：

10.3816/CCC.2007.n.030

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The management of rectal cancer has undergone significant evolution with advances in surgery, radiation therapy, and chemotherapy. These advances have translated into improved rates of local control, survival, and quality of life. More recently, the integration of newer chemotherapeutic and targeted agents in patients with advanced colorectal cancer have led to further improvements in disease-free survival and overall survival. These agents are now being studied with radiation therapy in the neoadjuvant therapy of rectal cancer.

引用

页码：625 / 633

页数：9

共 89 条

[1] Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].

Andre, T ;

Boni, C ;

Mounedji-Boudiaf, L ;

Navarro, M ;

Tabernero, J ;

Hickish, T ;

Topham, C ;

Zaninelli, M ;

Clingan, P ;

Bridgewater, J ;

Tabah-Fisch, I ;

de Gramont, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2343-2351

[2]

[Anonymous], 1985, NEW ENGL J MED, V312, P1465

[3] Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer -: art. no. 62 [J].

Azria, D ;

Bibeau, F ;

Barbier, N ;

Zouhair, A ;

Lemanski, C ;

Rouanet, P ;

Ychou, M ;

Ozsahin, M ;

Pèlegrin, AP ;

Dubois, JB ;

Thèzenas, ST .

BMC CANCER, 2005, 5 (1)

[4] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].

Bonner, JA ;

Harari, PM ;

Giralt, J ;

Azarnia, N ;

Shin, DM ;

Cohen, RB ;

Jones, CU ;

Sur, R ;

Raben, D ;

Jassem, J ;

Ove, R ;

Kies, MS ;

Baselga, J ;

Youssoufian, H ;

Amellal, N ;

Rowinsky, EK ;

Ang, KK .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578

[5] Chemotherapy with preoperative radiotherapy in rectal cancer [J].

Bosset, Jean-Francois ;

Collette, Laurence ;

Calais, Gilles ;

Mineur, Laurent ;

Maingon, Philippe ;

Radosevic-Jelic, Ljiljana ;

Daban, Alain ;

Bardet, Etienne ;

Beny, Alexander ;

Ollier, Jean-Claude .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (11) :1114-1123

[6] Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy [J].

Bujko, K ;

Nowacki, MP ;

Nasierowska-Guttmejer, A ;

Michalski, W ;

Bebenek, AB ;

Pudelko, M ;

Kryj, A ;

Oledzki, J ;

Szmeja, J ;

Sluszniak, J ;

Serkies, K ;

Kladny, J ;

Pamucka, A ;

Kukolowicz, P .

RADIOTHERAPY AND ONCOLOGY, 2004, 72 (01) :15-24

[7]

CASCINUS S, 2001, P AN M AM SOC CLIN, V20, P26

[8]

Cassidy J, 2004, J CLIN ONCOL, V22, p247S

[9] Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer [J].

Chin, KF ;

Greenman, J ;

Gardiner, E ;

Kumar, H ;

Topping, K ;

Monson, J .

BRITISH JOURNAL OF CANCER, 2000, 83 (11) :1425-1431

[10]

Ciardiello F, 2000, CLIN CANCER RES, V6, P2053

← 1 2 3 4 5 6 7 8 9 →